Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NTLANTLA
Showing 8 of 31 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in INTELLIA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 164,712 shares of NTLA (INTELLIA THERAPEUTICS INC), worth $2.8M as of 2026-Q2. The position was decreased (-64.1% shares). NTLA represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.8M

Current Shares

164,712

Total Value Change

-$17.5M

Total Shares Change

-824,727

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
164,712
-64.1%
$2.8M0.0%$16.92
0
2026-Q1
Decreased
458,241
-51.8%
$5.9M0.0%$13.60
0
2025-Q4
Increased
950,250
+9076.7%
$8.5M0.0%$9.06
44
2025-Q3
Decreased
10,355
-98.5%
$178,8310.0%$16.92
0
2025-Q2
Decreased
709,981
-74.3%
$6.7M0.0%$9.56
0
2025-Q1
Increased
2.8M
+10.6%
$19.6M0.0%$8.07
31
2024-Q4
Increased
2.5M
+152.1%
$29.1M0.0%$11.41
46
2024-Q3
Increased
989,439
+29.7%
$20.3M0.0%$21.00
36

Other major holders of NTLA: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used